New Kitted NGS Panel Launches Targeting Lymphoid Malignancies
Research-use kit interrogates 84 genes using single-tube protocol, compatible with existing molecular laboratory equipment.
Research-use kit interrogates 84 genes using single-tube protocol, compatible with existing molecular laboratory equipment.
Research demonstrates 13% relative reduction in prostate cancer deaths but highlights overdiagnosis concerns, prompting calls for risk-based screening approaches.
UCLA Health researchers find cell-free DNA combined with machine learning can distinguish ALS from other neurological conditions.
A new study demonstrates the capability of a blood test in detecting ovarian cancer up to three years prior to diagnosis in prospectively collected samples.Â
Sample-to-answer assay delivers results in approximately 45 minutes from nasopharyngeal and nasal swab specimens.
Researchers urge clinicians to integrate lipid management into prenatal care to mitigate elevated obstetric complications and cardiovascular risks.
The multiplex immunoassay measures autoantibodies to the 14-3-3eta protein and aims to reduce diagnostic delays that currently average seven to 10 years.
The quantitative measurement test is designed to aid in myocardial infarction diagnosis using human plasma samples.
Roche's Elecsys pTau181 assay gives clinical labs a key role in the initial evaluation of cognitive decline, helping to rule out amyloid pathology earlier in the diagnostic process.
The automated system uses ion exchange HPLC technology to deliver A1c results while detecting common hemoglobin variants.
The agreement aims to improve early detection and management of chronic kidney disease in underserved populations through integrated diagnostics and digital health solutions.
The Cystic Fibrosis Base assay has received IVDR accreditation, ensuring high standards for detecting cystic fibrosis mutations.
TriVerity system demonstrated high sensitivity and specificity across more than 1,200 patients in pivotal SEPSIS-SHIELD trial.